Current status of Vitamin D signaling and its therapeutic applications

Current Topics in Medicinal Chemistry

Volumn 12, Issue 6, 2012, Pages 528-547

  Carlberg, Carsten ^a   Molnár, Ferdinand ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Crystal structure; Gene regulation; Genome wide view; Nuclear receptor; Vitamin D; Vitamin D analogues; Vitamin D receptor

Indexed keywords

1ALPHA HYDROXY 2 METHYLENE 19 NOR BISHOMOPREGNACALCIFEROL; 2 METHYLENE 19 NORCALCITRIOL; 20 EPICALCITRIOL; 2ALPHA METHYL 19 NORCALCITRIOL; 3 [4 [3 [4 (2 HYDROXY 3,3 DIMETHYLBUTOXY) 3 METHYLPHENYL]PENTAN 3 YL] 2 METHYLPHENOXY]PROPANE 1,2 DIOL; CALCIPOTRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; CD 4528; CELL NUCLEUS RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; LEXACALCITOL; LG 190178; SEOCALCITOL; TX 522; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; YR 301;

AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL GROWTH; CHEMICAL STRUCTURE; CHROMATIN; CRYSTAL STRUCTURE; DNA BINDING; DRUG RECEPTOR BINDING; GENE TARGETING; HISTONE MODIFICATION; HUMAN; INFECTION; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PROSTATE HYPERTROPHY; PROTEIN PROCESSING; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VITAMIN D RESPONSIVE ELEMENT; VITAMIN METABOLISM;

ANIMALS; DISEASE; HUMANS; LIGANDS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 84857735521     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612799436623     Document Type: Review

References (184)

1. Lawson, D.E.; Fraser, D.R.; Kodicek, E.; Morris, H.R.; Williams, D.H. Identification of 1,25-dihydroxycholecalciferol, a new kidneyhormone controlling calcium metabolism. Nature, 1971, 230, 228-230.
2. Norman, A.W.; Myrtle, J.F.; Midgett, R.J.; Nowicki, H.G.; Williams, V.; Popjak, G. 1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine. Science, 1971, 173, 51-54.
3. Haussler, M.; Norman, A.W. Chromosomal receptor for a vitamin D metabolite. Proc. Natl. Acad. Sci., 1969, 62, 155-162.
4. McDonnell, D.P.; Mangelsdorf, D.J.; Pike, J.W.; Haussler, M.R.; OMalley, B.W. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science, 1987, 235, 1214-1217.
5. Evans, R.M. The steroid and thyroid hormone receptor superfamily. Science, 1988, 240, 889-895.
6. Mangelsdorf, D.J.; Thummel, C.; Beato, M.; Herrlich, P.; Schütz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Chambon, P.; Evans, R.M. The nuclear receptor superfamily: the second decade. Cell, 1995, 83, 835-839.
7. Chawla, A.; Repa, J.J.; Evans, R.M.; Mangelsdorf, D.J. Nuclear receptors and lipid physiology: opening the X-files. Science, 2001, 294, 1866-1870.
8. Carlberg, C. Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling. Eur. J. Biochem., 1995, 231, 517-527.
9. Carlberg, C.; Molnar, F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. Curr. Top.Med. Chem., 2006, 6, 1243-1253.
10. Carlberg, C.; Seuter, S. Dynamics of nuclear receptor target gene regulation. Chromosoma, 2010, 119, 479-484.
11. Pike, J.W. Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand. Mol. Cell Endocrinol., 2011, 347, 3-10.
12. Renkema, K.Y.; Alexander, R.T.; Bindels, R.J.; Hoenderop, J.G. Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann. Med., 2008, 40, 82-91.
13. Razin, A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J., 1998, 17, 4905-4908.
14. Mohn, F.; Schubeler, D. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet., 2009, 25, 129-136.
15. Talbert, P.B.; Henikoff, S. Spreading of silent chromatin: inaction at a distance. Nat. Rev. Genet., 2006, 7, 793-803.
16. Narlikar, G.J.; Fan, H.Y.; Kingston, R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell, 2002, 108, 475-487.
17. Jenuwein, T.; Allis, C.D. Translating the histone code. Science, 2001, 293, 1074-1080.
18. Hager, G.L.; Nagaich, A.K.; Johnson, T.A.; Walker, D.A.; John, S. Dynamics of nuclear receptor movement and transcription. Biochim. Biophys. Acta, 2004, 1677, 46-51.
19. Metivier, R.; Reid, G.; Gannon, F. Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep., 2006, 7, 161-167.
20. Trotter, K.W.; Archer, T.K. Nuclear receptors and chromatin remodeling machinery. Mol. Cell Endocrinol., 2007, 265-266, 162-167.
21. George, A.A.; Schiltz, R.L.; Hager, G.L. Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int. J. Biochem. Cell Biol., 2009, 41, 214-224.
22. Aranda, A.; Pascual, A. Nuclear hormone receptors and gene expression. Physiol. Rev., 2001, 81, 1269-1304.
23. Burke, L.J.; Baniahmad, A. Co-repressors 2000. FASEB J., 2000, 14, 1876-1888.
24. Xu, L.; Glass, C.K.; Rosenfeld, M.G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev., 1999, 9, 140-147.
25. Leo, C.; Chen, J.D. The SRC family of nuclear receptor coactivators. Gene, 2000, 245, 1-11.
26. Glass, C.K.; Rosenfeld, M.G. The coregulator exchange intranscriptional functions of nuclear receptors. Gen. Dev., 2000, 14, 121-141.
27. Rachez, C.; Lemon, B.D.; Suldan, Z.; Bromleigh, V.; Gamble, M.; Näär, A.M.; Erdjument-Bromage, H.; Tempst, P.; Freedman, L.P. Ligand-dependent transcription activation by nuclear receptorsrequires the DRIP complex. Nature, 1999, 398, 824-828.
28. Malinen, M.; Saramäki, A.; Ropponen, A.; Degenhardt, T.; Väisänen, S.; Carlberg, C. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and α,25-dihydroxyvitamin D3. Nucleic Acids Res., 2008, 36, 121-132.
29. Carlberg, C.; Polly, P. Gene regulation by vitamin D3. Crit. Rev.Eukaryot. Gene. Exp., 1998, 8, 19-42.
30. Hard, T.; Kellenbach, E.; Boelens, R.; Maler, B.A.; Dahlman, K.; Freedman, L.P.; Carlstedt-Duke, J.; Yamamoto, K.R.; Gustafsson, J.A.; Kaptein, R. Solution structure of the glucocorticoid receptorDNA-binding domain. Science, 1990, 249, 157-160.
31. Lee, M.S.; Kliewer, S.A.; Provencal, J.; Wright, P.E.; Evans, R.M. Structure of the retinoid X receptor a DNA binding domain: a helix required for homodimeric DNA binding. Science, 1993, 260, 1117-1121.
32. Li, Y.; Lambert, M.H.; Xu, H.E. Activation of nuclear receptors: a perspective from structural genomics. Structure, 2003, 11, 741-746.
33. Nagy, L.; Schwabe, J.W. Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci., 2004, 29, 317-324.
34. Brzozowski, A.M.; Pike, A.C.W.; Dauter, Z.; Hubbard, R.E.; Bonn, T.; Engström, O.; Öhman, L.; Greene, G.L.; Gustafsson, J.-A.; Carlquist, M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 1997, 389, 753-758.
35. Nolte, R.T.; Wisley, G.B.; Westin, S.; Cobb, J.E.; Lambert, J.E.; Lambert, M.H.; Kurokawa, R.; Rosenfeld, M.G.; Willson, T.M.; Glass, C.K.; Milburn, M.V. Ligand-binding and co-activator assembly of the peroxisome proliferator-activated receptor-g. Nature, 1998, 395, 137-143.
36. Molnar, F.; Matilainen, M.; Carlberg, C. Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators. J. Biol. Chem., 2005, 280, 26543-26556.
37. Kallenberger, B.C.; Love, J.D.; Chatterjee, V.K.; Schwabe, J.W. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Nat. Struct. Biol., 2003, 10, 136-140.
38. Heery, D.M.; Kalkhoven, E.; Hoare, S.; Parker, M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature, 1997, 387, 733-736.
39. Hu, X.; Lazar, M.A. The Co RNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature, 1999, 402, 93-96.
40. Moras, D.; Gronemeyer, H. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol., 1998, 10, 384-391.
41. Sutton, A.L.; MacDonald, P.N. Vitamin D: more than a bone-afide hormone. Mol. Endocrinol., 2003, 17, 777-791.
42. Verstuyf, A.; Carmeliet, G.; Bouillon, R.; Mathieu, C. Vitamin D: a pleiotropic hormone. Kidney Int., 2010, 78, 140-145.
43. Suda, T.; Ueno, Y.; Fujii, K.; Shinki, T. Vitamin D and bone. J. Cell Biochem., 2003, 88, 259-266.
44. Mørk Hansen, C.; Binderup, L.; Hamberg, K.J.; Carlberg, C. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci., 2001, 6, D820-D848.
45. Juzutka, P.W.; Remus, L.S.; Whitfield, G.K.; Thompson, P.D.; Hsieh, J.-C.; Zitzer, H.; Tavakkoli, P.; Galligan, M.A.; Dang, H.T.L.; Haussler, C.A.; Haussler, M.R. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with the transcription factor IIB. Mol. Endocrinol., 2000, 14, 401-420.
46. Gross, C.; Krishnan, A.V.; Malloy, P.J.; Eccleshall, T.R.; Zhao, X.-Y.; Feldman, D. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J. Bone Miner. Res., 1998, 13, 1691-1699.
47. Huhtakangas, J.A.; Olivera, C.J.; Bishop, J.E.; Zanello, L.P.; Norman, A.W. The vitamin D receptor is present in caveolaeenriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Mol. Endocrinol., 2004, 18, 2660-2671.
48. Zhao, G.; Simpson, R.U. Interaction between vitamin D receptor with caveolin-3 and regulation by 1,25-dihydroxyvitamin D3 in adult rat cardiomyocytes. J. Steroid. Biochem. Mol. Biol., 2010, 121, 159-163.
49. Rochel, N.; Wurtz, J.M.; Mitschler, A.; Klaholz, B.; Moras, D. Crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell, 2000, 5, 173-179.
50. Renaud, J.-P.; Rochel, N.; Ruff, M.; Vivat, V.; Chambon, P.; Gronemeyer, H.; Moras, D. Crystal structure of the RAR-g ligandbinding domain bound to all-trans retinoic acid. Nature, 1995, 378, 681-689.
51. Bouillon, R.; Okamura, W.H.; Norman, A.W. Structure-function relationships in the vitamin D endocrine system. Endocrine. Rev., 1995, 16, 200-257.
52. Carlberg, C.; Bendik, I.; Wyss, A.; Meier, E.; Sturzenbecker, L.J.; Grippo, J.F.; Hunziker, W. Two nuclear signalling pathways for vitamin D. Nature, 1993, 361, 657-660.
53. Glass, C.K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev., 1994, 15, 391-407.
54. Rastinejad, F.; Perlmann, T.; Evans, R.M.; Sigler, P.B. Structuraldeterminants of nuclear receptor assembly on DNA direct repeats. Nature, 1995, 375, 203-211.
55. Umesono, K.; Murakami, K.K.; Thompson, C.C.; Evans, R.M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell, 1991, 65, 1255-1266.
56. Quelo, I.; Kahlen, J.P.; Rascle, A.; Jurdic, P.; Carlberg, C. Identification and characterization of a vitamin D3 response element of chicken carbonic anhydrase-II. DNA Cell Biol., 1994, 13, 1181-1187.
57. Schräder, M.; Nayeri, S.; Kahlen, J.P.; Müller, K.M.; Carlberg, C. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell Biol., 1995, 15, 1154-1161.
58. Rochel, N.; Ciesielski, F.; Godet, J.; Moman, E.; Roessle, M.; Peluso-Iltis, C.; Moulin, M.; Haertlein, M.; Callow, P.; Mély, Y.; Svergun, D.; Moras, D. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nat. Struct. Mol. Biol., 2011, 18, 564-570.
59. Zhang, J.; Chalmers, M.; Stayrook, K.; Burris, L.; Wang, Y.; Busby, S.; Pascal, B.; Garcia-Ordonez, R.; Bruning, J.; Istrate, M.; Kojetin, D.; Dodge, J.; TP, B.; Griffin, P. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat. Struct. Mol. Biol., 2011, 18, 556-563.
60. Quack, M.; Carlberg, C. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4- type response elements. J. Mol. Biol., 2000, 296, 743-756.
61. Schräder, M.; Müller, K.M.; Nayeri, S.; Kahlen, J.P.; Carlberg, C.VDR-T3R receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature, 1994, 370, 382-386.
62. Heikkinen, S.; Väisänen, S.; Pehkonen, P.; Seuter, S.; Benes, V.; Carlberg, C. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicts agenome-wide shift in the locations of VDR chromatin accupancy. Nucl. Acids Res., 2011, 39, 9181-9193.
63. Schräder, M.; Bendik, I.; Becker-Andre, M.; Carlberg, C. Interaction between retinoic acid and vitamin D signaling pathways. J. Biol. Chem., 1993, 268, 17830-17836.
64. Schräder, M.; Müller, K.M.; Carlberg, C. Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J. Biol. Chem.,1994, 269, 5501-5504.
65. Matys, V.; Fricke, E.; Geffers, R.; Gossling, E.; Haubrock, M.; Hehl, R.; Hornischer, K.; Karas, D.; Kel, A.E.; Kel-Margoulis, O.V.; Kloos, D.U.; Land, S.; Lewicki-Potapov, B.; Michael, H.; Munch, R.; Reuter, I.; Rotert, S.; Saxel, H.; Scheer, M.; Thiele, S.; Wingender, E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res., 2003, 31, 374-378.
66. Väisänen, S.; Dunlop, T.W.; Sinkkonen, L.; Frank, C.; Carlberg, C. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1α,25-dihydroxyvitamin D3. J. Mol. Biol., 2005, 350, 65-77.
67. Turunen, M.M.; Dunlop, T.W.; Carlberg, C.; Väisänen, S. Selective use of multiple vitamin D response elements underlies the 1α,25- dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res., 2007, 35, 2734-2747.
68. Sinkkonen, L.; Malinen, M.; Saavalainen, K.; Väisänen, S.; Carlberg, C. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. Nucleic Acids Res., 2005, 33, 2440-2451.
69. Saramäki, A.; Banwell, C.M.; Campbell, M.J.; Carlberg, C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res., 2006, 34, 543-554.
70. Saramäki, A.; Diermeier, S.; Kellner, R.; Laitinen, H.; Väisänen, S.; Carlberg, C. Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1α,25-dihydroxyvitamin D3. J. Biol. Chem., 2009, 284, 8073-8082.
71. Bulger, M.; Groudine, M. Looping versus linking: toward a model for long-distance gene activation. Genes. Dev., 1999, 13, 2465-2477.
72. Matilainen, M.; Malinen, M.; Saavalainen, K.; Carlberg, C. Regulation of multiple insulin-like growth factor binding protein genes by 1α,25-dihydroxyvitamin D3. Nucleic Acids Res., 2005, 33, 5521-5532.
73. Seuter, S.; Väisänen, S.; Radmark, O.; Carlberg, C.; Steinhilber, D. Functional characterization of vitamin D responding regions in the human 5-lipoxygenase gene. Biochim. Biophys. Acta, 2007, 1771, 864-872.
74. Krishnan, A.V.; Shinghal, R.; Raghavachari, N.; Brooks, J.D.; Peehl, D.M.; Feldman, D. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Prostate, 2004, 59, 243-251.
75. Meyer, M.B.; Watanuki, M.; Kim, S.; Shevde, N.K.; Pike, J.W. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol., 2006, 20, 1447-1461.
76. Xu, H.; Bai, L.; Collins, J.F.; Ghishan, F.K. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)2 vitamin D3. Am. J. Physiol. Cell Physiol., 2002, 282, C487-493.
77. Saito, H.; Maeda, A.; Ohtomo, S.; Hirata, M.; Kusano, K.; Kato, S.; Ogata, E.; Segawa, H.; Miyamoto, K.; Fukushima, N. Circulating FGF-23 is regulated by 1α,25-dihydroxyvitamin D3 and phosphorus in vivo. J. Biol. Chem., 2005, 280, 2543-2549.
78. Kim, S.; Yamazaki, M.; Zella, L.A.; Shevde, N.K.; Pike, J.W. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol. Cell Biol., 2006, 26, 6469-6486.
79. Jiang, H.; Lin, J.; Su, Z.; Collart, F.R.; Huberman, E.; Fisher, P.B. Induction of differentiation in human promyelotic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 1994, 9, 3397-3406.
80. Wang, Q.M.; Jones, J.B.; Studzinski, G.P. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res., 1996, 56, 264-267.
81. Liu, M.; Iavarone, A.; Freedman, L.P. Transcriptional activation of the human p21WAF1/CIP1 gene by retinoic acid receptor. J. Biol. Chem., 1996, 271, 31723-31728.
82. Tavera-Mendoza, L.; Wang, T.T.; Lallemant, B.; Zhang, R.; Nagai, Y.; Bourdeau, V.; Ramirez-Calderon, M.; Desbarats, J.; Mader, S.; White, J.H. Convergence of vitamin D and retinoic acid signaling at a common hormone response element. EMBO Rep., 2006, 7, 180-185.
83. Verlinden, L.; Verstuyf, A.; Convents, R.; Marcelis, S.; Van Camp, M.; Bouillon, R. Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol. Cell Endocrinol., 1998, 142, 57-65.
84. Rickert, P.; Seghezzi, W.; Shanahan, F.; Cho, H.; Lees, E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene, 1996, 12, 2631-2640.
85. Li, H.; Lahti, J.M.; Valentine, M.; Saito, M.; Reed, S.I.; Look, A.T.; Kidd, V.J. Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors. Genomics, 1996, 32, 253-259.
86. Akutsu, N.; Lin, R.; Bastien, Y.; Bestawros, A.; Enepekides, D.J.; Black, M.J.; White, J.H. Regulation of gene Expression by 1α,25-dihydroxyvitamin D3 and its analog EB1089 under growthinhibitory conditions in squamous carcinoma Cells. Mol. Endocrinol., 2001, 15, 1127-1139.
87. Zhan, Q.; Antinore, M.J.; Wang, X.W.; Carrier, F.; Smith, M.L.; Harris, C.C.; Fornace, A.J. Jr. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene, 1999, 18, 2892-2900.
88. Jiang, F.; Li, P.; Fornace, A.J. Jr.; Nicosia, S.V.; Bai, W. G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J. Biol. Chem., 2003, 278, 48030-48040.
89. Peng, L.; Malloy, P.J.; Feldman, D. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol. Endocrinol., 2004, 18, 1109-1119.
90. Dunlop, T.W.; Väisänen, S.; Frank, C.; Molnar, F.; Sinkkonen, L.; Carlberg, C. The human peroxisome proliferator-activated receptor d gene is a primary target of 1α,25-dihydroxyvitamin D3 and its nuclear receptor. J. Mol. Biol., 2005, 349, 248-260.
91. Reed, K.R.; Sansom, O.J.; Hayes, A.J.; Gescher, A.J.; Winton, D.J.; Peters, J.M.; Clarke, A.R. PPARd status and Apc-mediated tumourigenesis in the mouse intestine. Oncogene, 2004, 23, 8992-8996.
92. Palmer, H.G.; Sanchez-Carbayo, M.; Ordonez-Moran, P.; Larriba, M.J.; Cordon-Cardo, C.; Munoz, A. Genetic signatures of differentiation induced by 1α,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res., 2003, 63, 7799-7806.
93. Khanim, F.L.; Gommersall, L.M.; Wood, V.H.; Smith, K.L.; Montalvo, L.; O'Neill, L.P.; Xu, Y.; Peehl, D.M.; Stewart, P.M.; Turner, B.M.; Campbell, M.J. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene, 2004, 23, 6712-6725.
94. Peehl, D.M.; Shinghal, R.; Nonn, L.; Seto, E.; Krishnan, A.V.; Brooks, J.D.; Feldman, D. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. J. Steroid. Biochem. Mol. Biol., 2004, 92, 131-141.
95. Ikezoe, T.; Gery, S.; Yin, D.; O'Kelly, J.; Binderup, L.; Lemp, N.; Taguchi, H.; Koeffler, H.P. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgenresponsive prostate cancer LNCaP cells. Cancer Res., 2005, 65, 4762-4768.
96. Swami, S.; Raghavachari, N.; Muller, U.R.; Bao, Y.P.; Feldman, D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res. Treat., 2003, 80, 49-62.
97. Eelen, G.; Verlinden, L.; Van Camp, M.; Mathieu, C.; Carmeliet, G.; Bouillon, R.; Verstuyf, A. Microarray analysis of 1α,25- dihydroxyvitamin D3-treated MC3T3-E1 cells. J. Steroid. Biochem. Mol. Biol., 2004, 89-90, 405-407.
98. Eelen, G.; Verlinden, L.; van Camp, M.; van Hummelen, P.; Marchal, K.; de Moor, B.; Mathieu, C.; Carmeliet, G.; Bouillon, R.; Verstuyf, A. The effects of 1α,25-dihydroxyvitamin D3 on the expression of DNA replication genes. J. Bone Miner. Res., 2004, 19, 133-146.
99. Wang, T.T.; Tavera-Mendoza, L.E.; Laperriere, D.; Libby, E.; MacLeod, N.B.; Nagai, Y.; Bourdeau, V.; Konstorum, A.; Lallemant, B.; Zhang, R.; Mader, S.; White, J.H. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol., 2005, 19, 2685-2695.
100. Ramagopalan, S.V.; Heger, A.; Berlanga, A.J.; Maugeri, N.J.; Lincoln, M.R.; Burrell, A.; Handunnetthi, L.; Handel, A.E.; Disanto, G.; Orton, S.M.; Watson, C.T.; Morahan, J.M.; Giovannoni, G.; Ponting, C.P.; Ebers, G.C.; Knight, J.C. A ChIPseq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res., 2010, 20, 1352-1360.
101. Carlberg, C.; Dunlop, T.W.; Saramäki, A.; Sinkkonen, L; Matilainen, M.; Väisänen, S. Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites. J. Steroid Biochem. Mol. Biol., 2007, 103, 338-343.
102. Zella, L.A.; Kim, S.; Shevde, N.K.; Pike, J.W. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol., 2006, 20, 1231-1247.
103. Meyer, M.B.; Goetsch, P.D.; Pike, J.W. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 Expression by 1α,25-dihydroxyvitamin D3. J. Biol. Chem., 2010, 285, 15599-15610.
104. Fretz, J.A.; Zella, L.A.; Kim, S.; Shevde, N.K.; Pike, J.W. 1,25- Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol. Endocrinol., 2006, 20, 2215-2230.
105. Nielsen, R.; Pedersen, T.A.; Hagenbeek, D.; Moulos, P.; Siersbaek, R.; Megens, E.; Denissov, S.; Borgesen, M.; Francoijs, K.J.; Mandrup, S.; Stunnenberg, H.G. Genome-wide profiling of PPARg:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes. Dev., 2008, 22, 2953-2967.
106. Welboren, W.J.; van Driel, M.A.; Janssen-Megens, E.M.; van Heeringen, S.J.; Sweep, F.C.; Span, P.N.; Stunnenberg, H.G. ChIPSeq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. Embo. J., 2009, 28, 1418-1428.
107. Bunger, M.; Hooiveld, G.J.; Kersten, S.; Muller, M. Exploration of PPAR functions by microarray technology--a paradigm for nutrigenomics. Biochim. Biophys. Acta, 2007, 1771, 1046-1064.
108. Carroll, J.S.; Meyer, C.A.; Song, J.; Li, W.; Geistlinger, T.R.; Eeckhoute, J.; Brodsky, A.S.; Keeton, E.K.; Fertuck, K.C.; Hall, G.F.; Wang, Q.; Bekiranov, S.; Sementchenko, V.; Fox, E.A.; Silver, P.A.; Gingeras, T.R.; Liu, X.S.; Brown, M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet., 2006, 38, 1289-1297.
109. Farnham, P.J. Insights from genomic profiling of transcription factors. Nat. Rev. Genet., 2009, 10, 605-616.
110. Polly, P.; Herdick, M.; Moehren, U.; Baniahmad, A.; Heinzel, T.; Carlberg, C. VDR-Alien: a novel, DNA-selective vitamin D3 receptor-corepressor partnership. FASEB J., 2000, 14, 1455-1463.
111. Sanchez-Martinez, R.; Zambrano, A.; Castillo, A.I.; Aranda, A. Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol. Cell Biol., 2008, 28,3817-829.
112. Shang, Y.; Hu, X.; DiRenzo, J.; Lazar, M.A.; Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 2000, 103, 843-852.
113. Metivier, R.; Penot, G.; Hubner, M.R.; Reid, G.; Brand, H.; Kos, M.; Gannon, F. Estrogen receptor a directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 2003, 115, 751-763.
114. Kang, Z.; Pirskanen, A.; Jänne, O.A.; Palvimo, J.J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem., 2002, 277, 48366-48371.
115. Sharma, D.; Fondell, J.D. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc. Natl. Acad. Sci. USA, 2002, 99, 7934-7939.
116. Kim, S.; Shevde, N.K.; Pike, J.W. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res., 2005, 20, 305-317.
117. Malinen, M.; Ryynänen, J.; Heinäniemi, M.; Väisänen, S.; Carlberg, C. Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1α,25-dihydroxyvitamin D3. Nucleic Acids Res., 2011, 39, 502-512.
118. Toropainen, S.; Väisänen, S.; Heikkinen, S.; Carlberg, C. The down-regulation of the human MYC gene by the nuclear hormone 1α,25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. J. Mol. Biol., 2010, 400, 284-294.
119. Ashall, L.; Horton, C.A.; Nelson, D.E.; Paszek, P.; Harper, C.V.; Sillitoe, K.; Ryan, S.; Spiller, D.G.; Unitt, J.F.; Broomhead, D.S.; Kell, D.B.; Rand, D.A.; See, V.; White, M.R. Pulsatile stimulation determines timing and specificity of NF-kB-dependent transcription. Science, 2009, 324, 242-246.
120. Stavreva, D.A.; Wiench, M.; John, S.; Conway-Campbell, B.L.; McKenna, M.A.; Pooley, J.R.; Johnson, T.A.; Voss, T.C.; Lightman, S.L.; Hager, G.L. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat. Cell Biol., 2009, 11, 1093-1102.
121. Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr., 2004, 80, 1678S-1688S.
122. Jones, G.; Strugnell, S.A.; DeLuca, H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev., 1998, 78, 1193-1231.
123. Cheng, J.B.; Levine, M.A.; Bell, N.H.; Mangelsdorf, D.J.; Russell, D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA, 2004, 101, 7711-7715.
124. Takeyama, K.; Kitanaka, S.; Sato, T.; Kobori, M.; Yanagisawa, J.; Kato, S. 25-hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science, 1997, 277, 1827-1830.
125. Sakaki, T.; Sawada, N.; Komai, K.; Shiozawa, S.; Yamada, S.; Yamamoto, K.; Ohyama, Y.; Inouye, K. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur. J. Biochem., 2000, 267, 6158-6165.
126. Daiger, S.P.; Schanfield, M.S.; Cavalli-Sforza, L.L. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc. Natl. Acad. Sci. USA, 1975, 72, 2076-2080.
127. Norman, A.W.; Bishop, J.E.; Collins, E.D.; Seo, E.-G.; Satchell, D.P.; Dormanen, M.C.; Zanello, S.B.; Farach-Carson, M.C.; Bouillon, R.; Okamura, W.H. Differing shapes of 1α,25- dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report. J. Steroid. Biochem. Mol. Biol., 1996, 56, 13-22.
128. Carlberg, C. Molecular basis of the selective activity of vitamin D analogues. J. Cell Biochem., 2003, 88, 274-281.
129. Bury, Y.; Herdick, M.; Uskokovic, M.R.; Carlberg, C. Gene regulatory potential of 1α,25-dihydroxyvitamin D3 analogues with two side chains. J. Cell Biochem., 2001, 81, 179-190.
130. Macias Gonzalez, M.; Samenfeld, P.; Peräkylä, M.; Carlberg, C. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor. Mol. Endocrinol., 2003, 17, 2028-2038.
131. Tocchini-Valentini, G.; Rochel, N.; Wurtz, J.M.; Mitschler, A.; Moras, D. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc. Natl. Acad. Sci. USA, 2001, 98, 5491-5496.
132. Nayeri, S.; Mathiasen, I.S.; Binderup, L.; Carlberg, C. High affinity nuclear receptor binding of 20-epi analogues of 1,25-dihydroxyvitamin D3 correlates well with gene activation. J. Cell Biochem., 1996, 62, 325-333.
133. Bury, Y.; Ruf, D.; Mørk Hansen, C.; Kissmeyer, A.M.; Binderup, L.; Carlberg, C. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases. J. Invest. Dermatol., 2001, 116, 785-792.
134. Molnar, F.; Peräkylä, M.; Carlberg, C. Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket. J. Biol. Chem., 2006, 281, 10516-10526.
135. Tocchini-Valentini, G.; Rochel, N.; Wurtz, J.M.; Moras, D. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification. J. Med. Chem., 2004, 47, 1956-1961.
136. Eelen, G.; Verlinden, L.; Rochel, N.; Claessens, F.; De Clercq, P.; Vandewalle, M.; Tocchini-Valentini, G.; Moras, D.; Bouillon, R.; Verstuyf, A. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol. Pharmacol., 2005, 67, 1566-1573.
137. Vanhooke, J.L.; Benning, M.M.; Bauer, C.B.; Pike, J.W.; DeLuca, H.F. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry, 2004, 43, 4101-4110.
138. Verlinden, L.; Verstuyf, A.; Quack, M.; Van Camp, M.; Van Etten, E.; De Clercq, P.; Vandewalle, M.; Carlberg, C.; Bouillon, R. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. J. Bone. Miner. Res., 2001, 16, 625-638.
139. Hourai, S.; Rodrigues, L.; Antony, P.; Reina-San-Martin, B.; Ciesielski, F.; Magnier, B.; Schoonjans, K.; Mouriño, A.; Rochel, N.; Moras, D. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor. Chem. Biol., 2008, 15, 383-392.
140. Antony, P.; Sigüeiro, R.; Huet, T.; Sato, Y.; Ramalanjaona, N.; Rodrigues, L.; Mouriño, A.; Moras, D.; Rochel, N. Structure function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl- (20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3. J. Med. Chem., 2010, 53, 1159-1171.
141. Herdick, M.; Bury, Y.; Quack, M.; Uskokovic, M.; Polly, P.; Carlberg, C. Response element- and coactivator-mediated conformational change of the vitamin D3 receptor permits sensitive interaction with agonists. Mol. Pharmacol., 2000, 57, 1206-1217.
142. Väisänen, S.; Peräkylä, M.; Kärkkäinen, J.I.; Uskokovic, M.R.; Carlberg, C. Structural evaluation of a vitamin D analogue with two side chains. Mol. Pharmacol., 2003, 63, 1230-1237.
143. Inaba, Y.; Yoshimoto, N.; Sakamaki, Y.; Nakabayashi, M.; Ikura, T.; Tamamura, H.; Ito, N.; Shimizu, M.; Yamamoto, K. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor. J. Med. Chem., 2009, 12, 1438-1449.
144. Inaba, Y.; Nakabayashi, M.; Itoh, T.; Yoshimoto, N.; Ikura, T.; Ito, N.; Shimizu, M.; Yamamoto, K. 22S-butyl-1α,24Rdihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity. J. Steroid. Biochem. Mol. Biol., 2010, 121, 146-150.
145. Verstuyf, A.; Verlinden, L.; van Baelen, H.; Sabbe, K.; Hallewyn, C.; de Clercq, P.; Vanderwalle, M.; Bouillon, R. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. J. Bone Miner. Res., 1998, 13, 549-558.
146. Norman, A.W.; Manchand, P.S.; Uskokovic, M.R.; Okamura, W.H.; Takeuchi, J.A.; Bishop, J.E.; Hisatake, J.-I.; Koeffler, H.P.; Peleg, S. Characterization of a novel analog of 1α,25(OH)2-vitamin D3 with two side chains: interaction with its nuclear receptor and cellular actions. J. Med. Chem., 2000, 43, 2719-2730.
147. Yin, D.; He, Y.; Perera, M.A.; Hong, S.S.; Marhefka, C.; Stourman, N.; Kirkovsky, L.; Miller, D.D.; Dalton, J.T. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol. Pharmacol., 2003, 63, 211-223.
148. Fink, B.E.; Mortensen, D.S.; Stauffer, S.R.; Aron, Z.D.; Katzenellenbogen, J.A. Novel structural templates for estrogenreceptor ligands and prospects for combinatorial synthesis of estrogens. Chem. Biol., 1999, 6, 205-219.
149. Allegretto, E.A.; Boehm, M.F.; Nadzan, A.M. Vitamin D3 mimics. World Patent 2000, No. 00/10958.
150. Boehm, M.F.; Fitzgerald, P.; Zou, A.; Elgort, M.G.; Bischoff, E.D.; Mere, L.; Mais, D.E.; Bissonnette, R.P.; Heyman, R.A.; Nadzan, A.M.; Reichman, M.; Allegretto, E.A. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chem. Biol., 1999, 6, 265-275.
151. Swann, S.L.; Bergh, J.; Farach-Carson, M.C.; Ocasio, C.A.; Koh, J.T. Structure-based design of selective agonists for a ricketsassociated mutant of the vitamin D receptor. J. Am. Chem. Soc., 2002, 124, 13795-13805.
152. Swann, S.L.; Bergh, J.J.; Farach-Carson, M.C.; Koh, J.T. Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets. Org. Lett., 2002, 4, 3863-3866.
153. Perakyla, M.; Malinen, M.; Herzig, K.H.; Carlberg, C. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Mol. Endocrinol., 2005, 19, 2060-2073.
154. Kakuda, S.; Okada, K.; Eguchi, H.; Takenouchi, K.; Hakamata, W.; Kurihara, M.; Takimoto-Kamimura, M. Structure of the ligandbindingdomain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun., 2008, 64, 970-973.
155. Gajewski, R.; Jones, C.; Lu, J.; Ma, T.; Nagpal, S.; Yee, Y. Phenyfuran compounds as vitamin D receptor modulators. 2006, World Patent, 051936.
156. Toell, A.; Gonzalez, M.M.; Ruf, D.; Steinmeyer, A.; Ishizuka, S.; Carlberg, C. Different molecular mechanisms of vitamin D3 receptor antagonists. Mol. Pharmacol., 2001, 59, 1478-1485.
157. Herdick, M.; Steinmeyer, A.; Carlberg, C. Antagonistic action of a 25-carboxylic ester analogue of 1α,25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. J. Biol. Chem., 2000, 275, 16506-16512.
158. Bury, Y.; Steinmeyer, A.; Carlberg, C. Structure activity relationship of carboxylic ester antagonists of the vitamin D3 receptor. Mol. Pharmacol., 2000, 58, 1067-1074.
159. Miura, D.; Manabe, K.; Ozono, K.; Saito, M.; Gao, Q.; Norman, A.W.; Ishizuka, S. Antagonistic action of novel 1α,25-dihydroxyvitamin D3-26,23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1α,25-dihydroxyvitamin D3. J. Biol. Chem., 1999, 274, 16392-16399.
160. Miura, D.; Manabe, K.; Gao, Q.; Norman, A.W.; Ishizuka, S. 1α,25-dihydroxyvitamin D3-26,23-lactone analogues antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells). FEBS Lett., 1999, 460, 297-302.
161. Ozono, K.; Saiti, M.; Miura, D.; Michigami, T.; Nakajima, S.; Ishizuka, S. Analysis of the molecular mechanism for the antagonistic action of a novel 1α,25-dihydroxyvitamin D3 analogue toward vitamin D receptor function. J. Biol. Chem., 1999, 274, 32376-32381.
162. Väisänen, S.; Peräkylä, M.; Kärkkäinen, J.I.; Steinmeyer, A.; Carlberg, C. Critical role of helix 12 of the vitamin D3 receptor for the partial agonism of carboxylic ester antagonists. J. Mol. Biol., 2002, 315, 229-238.
163. Bula, C.M.; Bishop, J.E.; Ishizuka, S.; Norman, A.W. 25-Dehydro- 1α-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change. Mol. Endocrinol., 2000, 14, 1788-1796.
164. Peräkylä, M.; Molnar, F.; Carlberg, C. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling. Chem. Biol., 2004, 11, 1147-1156.
165. Saito, N.; Saito, H.; Anzai, M.; Yoshida, A.; Fujishima, T.; Takenouchi, K.; Miura, D.; Ishizuka, S.; Takayama, H.; Kittaka, A. Dramatic enhancement of antagonistic activity on vitamin Dreceptor: a double functionalization of 1α-hydroxyvitamin D3 26,23-lactones. Org. Lett., 2003, 5, 4859-4862.
166. Fujishima, T.; Kojima, Y.; Azumaya, I.; Kittaka, A.; Takayama, H. Design and synthesis of potent vitamin D receptor antagonists with A-ring modifications: remarkable effects of 2a-methyl introduction on antagonistic activity. Bioorg. Med. Chem., 2003, 11, 3621-3631.
167. Kakuda, S.; Ishizuka, S.; Eguchi, H.; Mizwicki, M.; Norman, A.; Takimoto-Kamimura, M. Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone. Acta Crystallogr. D. Biol. Crystallogr, 2010, 66, 918-926.
168. Nakabayashi, M.; Yamada, S.; Yoshimoto, N.; Tanaka, T.; Igarashi, M.; Ikura, T.; Ito, N.; Makishima, M.; Tokiwa, H.; DeLuca, H.; Shimizu, M. Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism. J. Med. Chem., 2008, 11, 5320-5329.
169. Rajakumar, K.; Greenspan, S.; Thomas, S.; Holick, M. SOLAR ultraviolet radiation and vitamin D: a historical perspective. Am. J. Public Health, 2007, 97, 1746-1754.
170. Institute of Medicine, Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press 2010.
171. Heaney, R.; Holick, M. Why the IOM recommendations for vitamin D are deficient. J. Bone Miner. Res., 2011, 26, 455-457.
172. Adams, J. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab. Clin. N. Am., 1989, 18, 765-778.
173. Staberg, B.; Roed-Petersen, J.; Menné, T. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue. Acta Derm. Venereol., 1989, 69, 147-150.
174. Deeb, K.K.; Trump, D.L.; Johnson, C.S. Vitamin D signallingpathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer, 2007, 7, 684-700.
175. Crescioli, C.; Ferruzzi, P.; Caporali, A.; Scaltriti, M.; Bettuzzi, S.; Mancina, R.; Gelmini, S.; Serio, M.; Villari, D.; Vannelli, G.; Colli, E.; Adorini, L.; Maggi, M. Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. Eur. J. Endocrinol., 2004, 140, 591-603.
176. Hourai, S.; Fujishima, T.; Kittaka, A.; Suhara, Y.; Takayama, H.; Rochel, N.; Moras, D. Probing a water channel near the A-ring of receptor-bound 1α,25-dihydroxyvitamin D3 with selected 2 alphasubstituted analogues. J. Med. Chem., 2006, 49, 5199-5205.
177. Molnár, F.; Sigüeiro, R.; Sato, Y.; Araujo, C.; Schuster, I.; Antony, P.; Peluso, J.; Muller, C.; Mouriño, A.; Moras, D.; Rochel, N. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS One, 2011, 6, e18124.
178. Rochel, N.; Hourai, S.; Moras, D. Crystal structure of hereditary vitamin D-resistant rickets--associated mutant H305Q of vitamin D nuclear receptor bound to its natural ligand. J. Steroid. Biochem. Mol. Biol., 2010, 121, 84-87.
179. Vanhooke, J.; Tadi, B.; Benning, M.; Plum, L.; DeLuca, H. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations. Arch. Biochem. Biophys., 2007, 460, 161-165.
180. Shimizu, M.; Miyamoto, Y.; Takaku, H.; Matsuo, M.; Nakabayashi, M.; Masuno, H.; Udagawa, N.; DeLuca, H.; Ikura, T.; Ito, N. 2-Substituted-16-ene-22-thia-1α,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure. Bioorg. Med. Chem., 2008, 16, 6949-6964.
181. Rochel, N.; Hourai, S.; Pérez-García, X.; Rumbo, A.; Mourino, A.; Moras, D. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol. Arch. Biochem. Biophys., 2007, 460, 172-176.
182. Ciesielski, F.; Rochel, N.; Moras, D. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation. J. Steroid. Biochem. Mol. Biol., 2007, 103, 235-242.
183. Eelen, G.; Valle, N.; Sato, Y.; Rochel, N.; Verlinden, L.; De Clercq, P.; Moras, D.; Bouillon, R.; Muñoz, A.; Verstuyf, A.Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor. Chem. Biol., 2008, 15, 383-392.
184. Huet, T.; Maehr, H.; Lee, H.; Uskokovic, M.; Suh, N.; Moras, D.; Rochel, N. Structure function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. Med. Chem. Comm., 2011, 8, 424-429.